Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.41 |
| ▸ | CFTR | P13569 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ANPEP | P15144 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8890450 | 0.84 | HPGD (0.54) | HPGDEPHX2TP53MEN1KMT2A | |
| SCHEMBL10308505 | 0.80 | HPGD (0.50) | HPGDEPHX2TP53MEN1KMT2A | |
| SCHEMBL456377 | 0.80 | HPGD (0.56) | HPGDTSHRCFTRFDPSANPEP | |
| SCHEMBL27926401 | 0.79 | HPGD (0.54) | HPGDEPHX2MEN1KMT2ATSHR | |
| SCHEMBL9762821 | 0.78 | HPGD (0.48) | HPGDEPHX2MEN1KMT2ATSHR | |
| SCHEMBL11569710 | 0.78 | HPGD (0.48) | HPGDEPHX2TP53MEN1KMT2A | |
| SCHEMBL388208 | 0.78 | HPGD (0.73) | HPGDEPHX2TSHRCALM1FDPS | |
| SCHEMBL27569486 | 0.78 | TP53 (0.48) | HPGDEPHX2TP53TSHRCALM1 | |
| SCHEMBL13536644 | 0.77 | SMN1; SMN2 (0.48) | TP53TSHRCYP2C19 | |
| SCHEMBL12891214 | 0.77 | HPGD (0.48) | HPGDTP53MEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12435181-B2 | Formulations capable of reacting with or removal of molecular oxygen | LI SHENSHEN (US) | 2025-10-07 | — | — | US | disclosed |
| US-20220235174-A1 | Formulations capable of reacting with or removal of molecular oxygen | LI ZHENZHEN (CN) | 2022-07-28 | — | — | US | disclosed |
| EP-3470398-B1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2022-05-04 | — | — | EP | disclosed |
| CN-113966271-A | Agent capable of reacting with or removing oxygen molecules | 李蓁蓁 | 2022-01-21 | — | — | CN | disclosed |
| US-20210083192-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2021-03-18 | — | — | US | disclosed |
| US-20200317704-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | NOVALED GMBH (DE) | 2020-10-08 | — | — | US | disclosed |
| WO-2019072932-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2019-04-18 | — | — | WO | disclosed |
| WO-2019072928-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | NOVALED GMBH (DE) | 2019-04-18 | — | — | WO | disclosed |
| EP-3470398-A1 | ORGANIC ELECTRONIC DEVICE COMPRISING AN ORGANIC SEMICONDUCTOR LAYER | Novaled GmbH (DE) | 2019-04-17 | — | — | EP | disclosed |
| US-8932735-B2 | Aromatic amine derivative and organic electroluminescent element comprising the same | IDEMITSU KOSAN CO., LTD. (JP) | 2015-01-13 | — | — | US | disclosed |
| US-20070191336-A1 | p38 kinase inhibitors | DECIPHERA PHARMACEUTICALS, LLC | 2007-08-16 | — | — | US | disclosed |
| US-7202257-B2 | Anti-inflammatory medicaments | DECIPHERA PHARMACEUTICALS, LLC (US) | 2007-04-10 | — | — | US | disclosed |
| US-20070055047-A1 | Molecular weight increase and modification of polycondensates | CIBA SPECIALTY CHEMICALS CORP. | 2007-03-08 | — | — | US | disclosed |
| US-20070037808-A1 | p38 kinase inhibitors | DECIPHERA PHARMACEUTICALS, LLC | 2007-02-15 | — | — | US | disclosed |
| US-20070027252-A1 | Process for improving color of polycondensates | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2007-02-01 | — | — | US | disclosed |
| US-20070004833-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | FERRO CORPORATION (US) | 2007-01-04 | — | — | US | disclosed |
| US-20070004937-A1 | METHODS FOR THE PREPARATION OF PHOSPHONIC ACID DERIVATIVES | FERRO CORPORATION (US) | 2007-01-04 | — | — | US | disclosed |
| EP-0156597-A2 | Process for the extraction of dilute amounts of carboxylic acids from liquid solutions | THE HALCON SD GROUP, INC. (US) | 1985-10-02 | — | — | EP | disclosed |
| US-4382898-A | Process for the production of aromatic carboxylic acid chlorides | BAYER AKTIENGESELLSCHAFT (DE) | 1983-05-10 | — | — | US | disclosed |
| US-3962326-A | CARBOXYLIC ACID OR ANHYDRIDE, PHOSGENE, TRISUBSTITUTED PHOSPHINE OXIDE OR SULFIDE | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037808-A1 | p38 kinase inhibitors | MAPK1, MAP3K8, MAP3K1 | HPGD 1844/4885EPHX2 3179/4885TP53 1137/4885 |
| US-20070004833-A1 | METHOD FOR THE PREPARATION OF ARALKYL DIALKYL PHOSPHONATES | ADK, ARAF, RPN1 | HPGD 2580/4885EPHX2 1065/4885TP53 3813/4885 |
| US-20070191336-A1 | p38 kinase inhibitors | MAPK1, MAP3K8, MAP3K1 | HPGD 1844/4885EPHX2 3179/4885TP53 1137/4885 |
| US-20210083192-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | SELE, EPCAM, OR51E2 | HPGD 4345/4885EPHX2 317/4885TP53 1644/4885 |
| US-20200317704-A1 | Organic Electronic Device Comprising an Organic Semiconductor Layer | SELE, EPCAM, OR51E2 | HPGD 4345/4885EPHX2 317/4885TP53 1644/4885 |
| US-20070004937-A1 | METHODS FOR THE PREPARATION OF PHOSPHONIC ACID DERIVATIVES | PDXK, PPA1, P2RY6 | HPGD 1363/4885EPHX2 424/4885TP53 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.